A Rare Case of Melanosis of the Hard Palate Mucosa in a Patient with Chronic Myeloid Leukemia
Imatinib Mesylate, also known as Gleevec or ST1-571, is a tyrosine-kinase inhibitor used as the gold standard medication for the chronic myeloid leukemia (CML); Imatinib has indeed deeply revolutionized the CML therapy allowing most patients to have a good quality of life. Despite its beneficial eff...
Saved in:
Main Authors: | Umberto Romeo, Gaspare Palaia, Paolo Junior Fantozzi, Gianluca Tenore, Daniela Bosco |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Dentistry |
Online Access: | http://dx.doi.org/10.1155/2015/817094 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histological Ex Vivo Evaluation of the Suitability of a 976 nm Diode Laser in Oral Soft Tissue Biopsies
by: Gaspare Palaia, et al.
Published: (2021-01-01) -
We still need to hit hard in acute myeloid leukemia, but only in the right patients
by: Arnold Ganser
Published: (2025-01-01) -
Melanosis with coincident vitiligo of the areola
by: Ramneek K. Dhami, et al.
Published: (2024-01-01) -
Primary spindle cell sarcoma of the hard palate: A rare case report and literature review
by: Shirley Silva, et al.
Published: (2024-03-01) -
Melanosis coli in patients with colon cancer
by: Dorota Biernacka-Wawrzonek, et al.
Published: (2016-12-01)